Latest Breaking News On - Avenue therapeutics inc - Page 17 : comparemela.com

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket

Gainers Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday..

Hong kongCarlotz incOblong incZai labConnexa sports technologies incZai lab limitedRomeo power incTherapeutics incDiamond therapeutics incGravitas education holdings incPharmaceuticals incEargo incQuanergy systems incWm technology incDigital brands group incZovio inc

Aegis Capital Corp Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc (NASDAQ:ATXI)

Aegis Capital Corp Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc (NASDAQ:ATXI)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesInvestment banking servicesAegis capital corporationAvenue therapeutics incMillion underwritten public therapeutics incTherapeutics incAegis capital corpWall streetAegis capitalSole bookrunnerUnderwritten public offeringAvenue therapeuticsFortress biotech specialty pharmaceuticalCapital corporationCapital corp

Aegis Capital Corp Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc

NEW YORK, NY / ACCESSWIRE / October 12, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc. (NASDAQ:ATXI).About Avenue Therapeutics

New yorkUnited statesInvestment banking servicesAegis capital corporationAvenue therapeutics incMillion underwritten public therapeutics incTherapeutics incAegis capital corpAegis capitalSole bookrunnerUnderwritten public offeringAvenue therapeuticsFortress biotech specialty pharmaceuticalCapital corporationCapital corp

Aegis Capital Corp Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc (NASDAQ:ATXI)

Aegis Capital Corp Acted as Sole Bookrunner on a $12 Million Underwritten Public Offering for Avenue Therapeutics, Inc (NASDAQ:ATXI)
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesInvestment banking servicesAegis capital corporationAvenue therapeutics incMillion underwritten public therapeutics incTherapeutics incAegis capital corpAegis capitalSole bookrunnerUnderwritten public offeringAvenue therapeuticsFortress biotech specialty pharmaceuticalCapital corporationCapital corp

Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering

Avenue Therapeutics Announces Closing of $12 Million Underwritten Public Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJaclyn jaffeBaergic bioKaufman canolesExchange commissionAvenue therapeutics incInvagen pharmaceuticals incAegis capital corpAvenue therapeuticsPrivate securities litigation reform act